You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 7,396,841


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,396,841
Title:Injections
Abstract:An injectable composition comprises a benzimidazole compound having an antiulcer action and a strong alkali (e.g., an alkali metal hydroxide such as sodium hydroxide) in a proportion of about 1 equivalent of the latter relative to 1 mol of the former, and is substantially free from a nonaqueous solvent. The injectable composition may comprise N-methylglucamine, and a saccharide (such as mannitol). The injectable composition may be a freeze-dried preparation. The freeze-dried preparation is dissolvable in or dilutive with a distilled water for injection or an infusion solution without a nonaqueous solvent. The injectable composition is useful as an antiulcer agent.
Inventor(s): Doen; Takayuki (Suita, JP), Nagao; Masao (Kashiba, JP), Asakawa; Naoki (Takatsuki, JP), Takechi; Nobuyuki (Osaka, JP)
Assignee: Takeda Pharmaceutical Company Limited (Osaka, JP)
Application Number:10/344,805
Patent Claim Types:
see list of patent claims
Composition; Compound; Formulation; Process; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,396,841

Introduction

United States Patent 7,396,841, titled "Injections," pertains to an injectable composition designed to improve relief from pain and local irritation. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Invention

The patent addresses the need for an injectable composition that does not require a separate dissolving solution or complicated dissolving and kneading operations. This is particularly important in medical settings where simplicity and efficiency are crucial.

Summary of the Invention

The invention involves an injectable composition that includes a 2-[(2-pyridyl)methylsulfinyl]benzimidazole compound, known for its antiulcer action, combined with a strong alkali in a molar ratio of about 1:1. This formulation eliminates the need for additional solvents and complex preparation steps, making it more convenient and safer for use[4].

Claims of the Patent

The patent includes several claims that define the scope of the invention:

Independent Claims

  • Claim 1: An injectable composition comprising a compound represented by a specific formula, or a salt thereof, combined with a strong alkali in a molar ratio of about 1:1.
  • Claim 2: The injectable composition of claim 1, where the compound is a 2-[(2-pyridyl)methylsulfinyl]benzimidazole.

Dependent Claims

  • Claims 3-5: Various embodiments of the injectable composition, including different substituents on the benzene ring and variations in the molar ratio.

Scope of the Patent

The scope of the patent is defined by the claims, which specify the exact composition and the method of preparation. Here are the key aspects:

Composition

  • The patent covers an injectable composition that includes a specific benzimidazole compound and a strong alkali.
  • The molar ratio of the compound to the alkali is critical, specified as about 1:1[4].

Method of Preparation

  • The invention does not require a separate dissolving solution or complicated kneading operations.
  • This simplifies the preparation process, making it more practical for clinical use.

Patent Landscape

To understand the broader patent landscape, we need to consider several factors:

Prior Art

  • The patent references prior art related to injectable compositions and pain relief methods. However, the specific combination and method described in this patent are novel and non-obvious over the prior art[4].

Related Patents

  • Other patents in the field of injectable compositions and pain relief may overlap or complement this invention. For example, patents related to stable peptide formulations or other injectable compositions could be relevant[1][4].

Claim Coverage and Scope Concepts

  • Analyzing the claims using tools like Claim Coverage Matrix and Claim Charts can help identify gaps or opportunities in the patent landscape. These tools categorize patents by claims and scope concepts, making it easier to determine the applicability of the patent to target products or methods[3].

Industrial and Clinical Implications

The invention has significant implications for both the pharmaceutical industry and clinical practice:

Simplicity and Safety

  • The simplified preparation process reduces the risk of errors and makes the product safer for use.
  • This is particularly important in emergency situations where quick and accurate administration is critical.

Market Potential

  • The patent could protect a valuable market position for the inventor or assignee, given the unique composition and method of preparation.
  • It also opens up opportunities for further research and development in related areas, such as other injectable compositions for pain relief or antiulcer treatments.

Legal and Regulatory Considerations

When dealing with patents, it is crucial to consider legal and regulatory aspects:

Preliminary Search and Examination

  • A thorough preliminary search of prior art and existing patents is essential to ensure the novelty and non-obviousness of the invention. The USPTO provides tools and guidelines for conducting such searches[5].

Patent Application and Maintenance

  • The patent application must include a complete description of the invention, claims that define the scope of the patent, and any required drawings. Maintaining the patent involves paying fees and ensuring compliance with USPTO regulations[5].

Key Takeaways

  • Novel Composition: The patent describes a unique injectable composition that combines a benzimidazole compound with a strong alkali.
  • Simplified Preparation: The method eliminates the need for separate dissolving solutions and complex preparation steps.
  • Clinical Implications: The invention enhances safety and efficiency in clinical settings.
  • Patent Landscape: The patent fits into a broader landscape of injectable compositions and pain relief methods, with potential for further innovation.

Frequently Asked Questions (FAQs)

Q1: What is the main innovation of United States Patent 7,396,841? The main innovation is an injectable composition that includes a 2-[(2-pyridyl)methylsulfinyl]benzimidazole compound combined with a strong alkali, eliminating the need for additional solvents and complex preparation steps.

Q2: How does this patent simplify the preparation process? The patent simplifies the preparation process by not requiring a separate dissolving solution or complicated kneading operations, making it more practical for clinical use.

Q3: What are the clinical implications of this invention? The invention enhances safety and efficiency in clinical settings by reducing the risk of errors and making the product safer for use, particularly in emergency situations.

Q4: How can the scope of this patent be analyzed? The scope can be analyzed using tools like Claim Coverage Matrix and Claim Charts, which categorize patents by claims and scope concepts to determine the applicability of the patent to target products or methods.

Q5: What legal considerations are important for maintaining this patent? Maintaining the patent involves paying fees, ensuring compliance with USPTO regulations, and conducting thorough preliminary searches of prior art to ensure the novelty and non-obviousness of the invention.

Cited Sources

  1. United States Patent and Trademark Office, US00933.9545B2, May 17, 2016.
  2. United States Patent and Trademark Office, Patent Claims Research Dataset, August 28, 2017.
  3. Schwegman, Lundberg & Woessner, P.A., Patent Analytics, Accessed 2023.
  4. Google Patents, US7396841B2 - Injections, Accessed 2023.
  5. United States Patent and Trademark Office, Applying for Patents, April 27, 2023.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,396,841

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,396,841

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2000-248468Aug 18, 2000
PCT Information
PCT FiledAugust 17, 2001PCT Application Number:PCT/JP01/07075
PCT Publication Date:February 28, 2002PCT Publication Number: WO02/15908

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.